Mobile App

Google Play Apple Store
Independent Coverage from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting*
Certified AMA Activity - Clinical Clips
Novel biomarker-driven approaches for the treatment of advanced/metastatic non-small cell lung cancer (NSCLC) continue to evolve at a rapid pace. Therefore, clinicians need to stay abreast with recently presented clinical trial data to provide updated molecular testing-based therapies for their patients with NSCLC.

These educational Clinical Clips will highlight important advances in biomarker-driven targeted therapy approaches for NSCLC based on data presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.
Review each video to claim AMA credit after completion of the brief Post-Test/Evaluations.
Mark A. Socinski, MD
Mark A. Socinski, MD
Executive Medical Director
AdventHealth Cancer Institute



 


*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the 2021 American Society of Clinical Oncology Virtual Annual Meeting (ASCO)
20
Supported by an independent educational grant from Amgen

Launch Date: June 8, 2021
Release Date: June 8, 2021
Expiration Date: May 31, 2022

May 31, 2022
Mini Module
7110
ClinicalClips_WebBanner.LungCancer(1150).gif
Hematology-Oncology